中文 | English
Return
Total: 2968 , 1/297
Show Home Prev Next End page: GO
Author:(Jun-ying LI)

1.Correlation between liver fibrosis degree and carotid plaque in patients with lean metabolic dysfunction-associated fatty liver disease

Shuai ZHANG ; Shoulu JIN ; Wanqing LI ; Xijing SHI ; Hao LIANG ; Hao DONG ; Dailong LU ; Ying ZHU ; Xiaoxing XIANG ; Jun LIU

Journal of Clinical Hepatology 2026;42(2):319-325

2.Association of liver fibrosis markers and inflammation markers with the risk of gallstones in patients with metabolic dysfunction-associated fatty liver disease

Shuai ZHANG ; Shoulu JIN ; Wanqing LI ; Xijing SHI ; Hao LIANG ; Hao DONG ; Dailong LU ; Ying ZHU ; Xiaoxing XIANG ; Jun LIU

Journal of Clinical Hepatology 2026;42(3):579-585

3.Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)

Chuan LIU ; Hong YOU ; Qing-Lei ZENG ; Yu Jun WONG ; Bingqiong WANG ; Ivica GRGUREVIC ; Chenghai LIU ; Hyung Joon YIM ; Wei GOU ; Bingtian DONG ; Shenghong JU ; Yanan GUO ; Qian YU ; Masashi HIROOKA ; Hirayuki ENOMOTO ; Amr Shaaban HANAFY ; Zhujun CAO ; Xiemin DONG ; Jing LV ; Tae Hyung KIM ; Yohei KOIZUMI ; Yoichi HIASA ; Takashi NISHIMURA ; Hiroko IIJIMA ; Chuanjun XU ; Erhei DAI ; Xiaoling LAN ; Changxiang LAI ; Shirong LIU ; Fang WANG ; Ying GUO ; Jiaojian LV ; Liting ZHANG ; Yuqing WANG ; Qing XIE ; Chuxiao SHAO ; Zhensheng LIU ; Federico RAVAIOLI ; Antonio COLECCHIA ; Jie LI ; Gao-Jun TENG ; Xiaolong QI

Clinical and Molecular Hepatology 2025;31(1):105-118

5.Safety and effectiveness of lecanemab in Chinese patients with early Alzheimer's disease: Evidence from a multidimensional real-world study.

Wenyan KANG ; Chao GAO ; Xiaoyan LI ; Xiaoxue WANG ; Huizhu ZHONG ; Qiao WEI ; Yonghua TANG ; Peijian HUANG ; Ruinan SHEN ; Lingyun CHEN ; Jing ZHANG ; Rong FANG ; Wei WEI ; Fengjuan ZHANG ; Gaiyan ZHOU ; Weihong YUAN ; Xi CHEN ; Zhao YANG ; Ying WU ; Wenli XU ; Shuo ZHU ; Liwen ZHANG ; Naying HE ; Weihuan FANG ; Miao ZHANG ; Yu ZHANG ; Huijun JU ; Yaya BAI ; Jun LIU

Chinese Medical Journal 2025;138(22):2907-2916

6.Reduction in RNF125-mediated RIG-I ubiquitination and degradation promotes renal inflammation and fibrosis progression.

Lu-Xin LI ; Ting-Ting JI ; Li LU ; Xiao-Ying LI ; Li-Min LU ; Shou-Jun BAI

Acta Physiologica Sinica 2025;77(3):385-394

7.Diagnostic Techniques and Risk Prediction for Cardiovascular-kidney-metabolic (CKM) Syndrome

Song HOU ; Lin-Shan ZHANG ; Xiu-Qin HONG ; Chi ZHANG ; Ying LIU ; Cai-Li ZHANG ; Yan ZHU ; Hai-Jun LIN ; Fu ZHANG ; Yu-Xiang YANG

Progress in Biochemistry and Biophysics 2025;52(10):2585-2601

8.Clinical effects of Pinggan Xifeng Huatan Tongluo Decoction on elderly patients with acute cerebral infarction complicated with hypertension

Ying-lu JIANG ; Miao-miao ZHANG ; Tao ZHANG ; Xue-jun LI

Chinese Traditional Patent Medicine 2025;47(10):3274-3278

9.TXNIP gene knockout ameliorates non-alcoholic fatty liver disease by regulating carbon flux of fatty acid synthesis and fatty acid oxidation

Jun-nan ZHAO ; Ai-yun LI ; Wan-zhen SU ; Xiao-xiao YIN ; Tong LI ; Xiang-ying JIAO

Chinese Pharmacological Bulletin 2025;41(8):1524-1530

10.Research progress in regulation of exosomes on diabetes encephalopathy and intervention of traditional Chinese medicine

Jie BU ; Ying LI ; Xue-ling LIN ; Peng-wei ZHUANG ; Yan-jun ZHANG ; Qing-sheng YIN

Chinese Pharmacological Bulletin 2025;41(8):1431-1435

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2968 , 1/297 Show Home Prev Next End page: GO